1. Home
  2. SMX vs LSTA Comparison

SMX vs LSTA Comparison

Compare SMX & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SMX (Security Matters) Public Limited Company

SMX

SMX (Security Matters) Public Limited Company

HOLD

Current Price

$1.86

Market Cap

18.8M

Sector

Technology

ML Signal

HOLD

Logo Lisata Therapeutics Inc.

LSTA

Lisata Therapeutics Inc.

BUY

Current Price

$1.03

Market Cap

15.9M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
SMX
LSTA
Founded
N/A
1980
Country
Ireland
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Misc Health and Biotechnology Services
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.8M
15.9M
IPO Year
2022
2000

Fundamental Metrics

Financial Performance
Metric
SMX
LSTA
Price
$1.86
$1.03
Analyst Decision
Hold
Analyst Count
0
2
Target Price
N/A
N/A
AVG Volume (30 Days)
104.7K
★ 239.4K
Earning Date
10-16-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 20.42
EPS
★ N/A
N/A
Revenue
N/A
★ $35,283,868.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 56.90
52 Week Low
$0.75
$0.98
52 Week High
$490.00
$5.07

Technical Indicators

Market Signals
Indicator
SMX
LSTA
Relative Strength Index (RSI) 18.44 34.66
Support Level $1.02 $0.99
Resistance Level $19.84 $1.28
Average True Range (ATR) 0.84 0.12
MACD -0.06 -0.02
Stochastic Oscillator 2.89 12.07

Price Performance

Historical Comparison
SMX
LSTA

About SMX SMX (Security Matters) Public Limited Company

SMX (Security Matters) PLC provides one solution to solve both authentication and track and trace challenges in order to uphold supply chain integrity and provide quality assurance and brand accountability to producers of goods. Its technology works as a track and trace system using a marker, a reader, and an algorithm to identify embedded sub-molecular particles in order to track and trace different components along a production process (or any other marked good along a supply chain) to the end producer.

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The company has one operating segment, the research and development of its investigational drug product.

Share on Social Networks: